GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 114 filers reported holding GOSSAMER BIO INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 200 | +98.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 101 | -99.8% | 0.00% | – |
| Q1 2023 | $52 | -98.3% | 41,580 | -97.1% | 0.00% | -100.0% |
| Q4 2022 | $3,109 | -99.8% | 1,432,620 | +838.5% | 0.00% | -50.0% |
| Q3 2022 | $1,830,000 | +4363.4% | 152,649 | +2965.9% | 0.00% | – |
| Q2 2022 | $41,000 | -97.5% | 4,979 | -96.6% | 0.00% | – |
| Q4 2021 | $1,638,000 | +1402.8% | 144,900 | +979.0% | 0.00% | – |
| Q2 2021 | $109,000 | +2080.0% | 13,429 | +2657.5% | 0.00% | – |
| Q1 2021 | $5,000 | -98.1% | 487 | -98.2% | 0.00% | – |
| Q4 2020 | $268,000 | -60.9% | 27,721 | -47.4% | 0.00% | -100.0% |
| Q2 2020 | $685,000 | +6750.0% | 52,714 | +5340.0% | 0.00% | – |
| Q1 2020 | $10,000 | – | 969 | +10666.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $1,447,000 | +2027.9% | 86,197 | +2646.9% | 0.00% | – |
| Q1 2019 | $68,000 | – | 3,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,275,726 | $43,399,000 | 17.96% |
| Boxer Capital, LLC | 2,185,000 | $22,178,000 | 1.51% |
| HHLR ADVISORS, LTD. | 5,911,541 | $60,002,000 | 0.81% |
| Artal Group S.A. | 1,808,968 | $18,361,000 | 0.78% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $4,667,000 | 0.46% |
| Spark Investment Management LLC | 39,906 | $405,000 | 0.22% |
| Alyeska Investment Group, L.P. | 476,838 | $4,840,000 | 0.10% |
| Cormorant Asset Management, LP | 198,382 | $2,014,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 36,101 | $366,000 | 0.09% |
| Redmile Group, LLC | 259,700 | $2,636,000 | 0.07% |